Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

被引：36
作者：
Barreto, L.
Guasparini, R.
Meekison, W.
Noya, F.
Young, L.
Mills, E.
机构：
[1] Sanofi Pasteur Ltd, Toronto, ON M2R 3T4, Canada
[2] Fraser Hlth Authority, Surrey, BC V3X 3A4, Canada
[3] Westcoast Clin Res, Coquitlam, BC V3C 4J2, Canada
[4] Montreal Childrens Hosp, Div Infect Dis, Montreal, PQ H3H 1P3, Canada
来源：
VACCINE | 2007年 / 25卷 / 48期
关键词：
pertussis; vaccine; serology;
D O I：
10.1016/j.vaccine.2007.09.031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Persistence of antibodies following a single dose of Tdap, vaccine (tetanus, diphtheria, and five-component acellular pertussis vaccine for use in individuals past childhood) was evaluated in a follow-up of adolescents (N = 324) and adults (N = 644) who had received Tdap in earlier clinical trials. Outcome measures were seroprotection (tetanus and diphtheria) or seropositivity (pertussis) and geometric mean titers. Humoral immune responses to all antigens were robust 1 month after initial immunization; antibodies exceeded pre-immunization levels 1, 3, and 5 years later. These data will contribute to selecting the optimal interval for booster doses of Tdap. Crown Copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：8172 / 8179
页数：8
相关论文
共 26 条
[1]   Infant pertussis - Who was the source? [J].
Bisgard, KM ;
Pascual, FB ;
Ehresmann, KR ;
Miller, CA ;
Cianfrini, C ;
Jennings, CE ;
Rebmann, CA ;
Gabel, J ;
Schauer, SL ;
Lett, SM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (11) :985-989
[2]   Recommendations are needed for adolescent and adult pertussis immunisation:: rationale and strategies for consideration [J].
Campins-Martí, M ;
Cheng, HK ;
Forsyth, K ;
Guiso, N ;
Halperin, S ;
Huang, LM ;
Mertsola, J ;
Oselka, G ;
Ward, J ;
von König, CHW ;
Zepp, F .
VACCINE, 2001, 20 (5-6) :641-646
[3]  
*CDC, 2006, MMWR-MORBID MORTAL W, V55, P21
[4]  
*CDC, 2006, MMWR-MORBID MORTAL W, V55, P22
[5]  
Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V54, P12
[6]   The epidemiology of pertussis:: A comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection [J].
Cherry, JD .
PEDIATRICS, 2005, 115 (05) :1422-1427
[7]   The science and fiction of the "resurgence" of pertussis [J].
Cherry, JD .
PEDIATRICS, 2003, 112 (02) :405-406
[8]   A search for serologic correlates of immunity to Bordetella pertussis cough illnesses [J].
Cherry, JD ;
Gornbein, J ;
Heininger, U ;
Stehr, K .
VACCINE, 1998, 16 (20) :1901-1906
[9]   Immunity to pertussis 5 years after booster immunization during adolescence [J].
Edelman, Kati ;
He, Qiushui ;
Makinen, Johanna ;
Sahlberg, Anna ;
Haanpera, Marjo ;
Schuerman, Lode ;
Wolter, Joanne ;
Mertsola, Jussi .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (10) :1271-1277
[10]   Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine [J].
Edelman, KJ ;
He, QS ;
Makinen, JP ;
Haanpera, MS ;
Minh, NNT ;
Schuerman, L ;
Wolter, J ;
Mertsola, JA .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :179-185
123